Company intelligence / Profile preview

ARS Treatment Centers

Turnersville, NJ, USAsamhsa.gov ↗

Ownership: Private
Development stage: Commercial

Overview

ARS Treatment Centers provides CARF-accredited outpatient medication-assisted treatment for opioid and other substance use disorders. Their programs combine medications such as methadone and buprenorphine with counseling services. They operate more than 60 facilities across five states in the U.S., serving over 22,000 patients monthly. The company emphasizes harm reduction and individualized care.

Therapeutic areas: Psychiatry
Modalities: Medication-assisted treatment (MAT)Small molecule (methadone)Small molecule (buprenorphine)Non-pharmacological therapy (counseling)
Industry: Non-Academic Healthcare

Partnerships

Medicaid/Medicare providers in multiple statesAccepts VA Community Care Network insuranceCollaborates with local healthcare providers for referrals

Beyond the preview

Go deeper on ARS Treatment Centers.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ARS Treatment Centers.

Explore the full profile